Boston Scientific Corp (BSX) stock
BSXNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 2, 2026Score 14/3048% below fair value
$43.03−0.66 (-1.51%)
Close on Nov 17, 2026Market cap $62.36BP/E 17.4Yield –
Boston Scientific pe ratio
The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.
Boston Scientific's pe ratio was 18.3× on Nov 11, 2026, against 54.3× a year earlier. Over the last 5 years it ranged from 17.0× to 115.8×, with a median of 68.2×.
PE Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 18.3× | −32.7 |
| 2025 | Dec 31, 2025 | 51.0× | −22.8 |
| 2024 | Dec 31, 2024 | 73.8× | +3.3 |
| 2023 | Dec 29, 2023 | 70.5× | −39.7 |
| 2022 | Dec 30, 2022 | 110.2× | +55.0 |
| 2021 | Dec 31, 2021 | 55.2× | +41.4 |
| 2020 | Dec 31, 2020 | 13.8× | – |
See a number that looks wrong?